Hlady_2012_J.Clin.Invest_122_163

Reference

Title : Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis - Hlady_2012_J.Clin.Invest_122_163
Author(s) : Hlady RA , Novakova S , Opavska J , Klinkebiel D , Peters SL , Bies J , Hannah J , Iqbal J , Anderson KM , Siebler HM , Smith LM , Greiner TC , Bastola D , Joshi S , Lockridge O , Simpson MA , Felsher DW , Wagner KU , Chan WC , Christman JK , Opavsky R
Ref : J Clinical Investigation , 122 :163 , 2012
Abstract : Hlady_2012_J.Clin.Invest_122_163
ESTHER : Hlady_2012_J.Clin.Invest_122_163
PubMedSearch : Hlady_2012_J.Clin.Invest_122_163
PubMedID: 22133874

Related information

Citations formats

Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J, Hannah J, Iqbal J, Anderson KM, Siebler HM, Smith LM, Greiner TC, Bastola D, Joshi S, Lockridge O, Simpson MA, Felsher DW, Wagner KU, Chan WC, Christman JK, Opavsky R (2012)
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis
J Clinical Investigation 122 :163

Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J, Hannah J, Iqbal J, Anderson KM, Siebler HM, Smith LM, Greiner TC, Bastola D, Joshi S, Lockridge O, Simpson MA, Felsher DW, Wagner KU, Chan WC, Christman JK, Opavsky R (2012)
J Clinical Investigation 122 :163